GLP-1 slows stomach emptying slightly, which may delay thyroid medication absorption if taken together
Common GLP-1 receptor agonist medications include semaglutide drugs such as Ozempic, Wegovy, and Rybelsus, as well as tirzepatide medications including Mounjaro and Zepbound
With significant weight loss, some users notice changes in facial appearance, often termed as Ozempic face. These changes typically include sagging or loose skin as a result of rapid weight loss
Contamination, incorrect strength, or unapproved ingredients are real risks, linked to serious harm and even death
Each weekly dose from 0.25mg2.4mg draws less than 0.5mL, keeping injection volume comfortable